{"id":"W3168954433","doi":"10.1016/j.jval.2021.04.800","title":"PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Socioeconomic status; Expanded Disability Status Scale; Pharmacy; Family medicine; Expanded access; Environmental health; Multiple sclerosis; Internal medicine; Population; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002284436,0.0002041858,0.000541303,0.0005530914,0.0002739235,0.0008917089,0.0002403022,0.0004001704,0.002643354],"category_scores_gemma":[0.01356045,0.00008476406,0.001089585,0.000789498,0.0002698219,0.0005717166,0.0007480604,0.001049854,0.0001230914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001703743,"about_ca_system_score_gemma":0.0009419632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00506547,"about_ca_topic_score_gemma":0.005649605,"domain_scores_codex":[0.9983038,0.001098921,0.0001322824,0.00006419938,0.0002586061,0.0001421704],"domain_scores_gemma":[0.9955438,0.00207652,0.001263687,0.0001299798,0.0003682091,0.0006177679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01599599,0.001063093,0.8101372,0.000794953,0.003359667,0.0003884918,0.0002105038,0.006670053,0.0002507629,0.003895848,0.004808659,0.1524246],"study_design_scores_gemma":[0.0009879607,0.003744709,0.9702404,0.0006022537,0.001471323,0.0004987363,0.0004814704,0.01228205,0.000240995,0.004267415,0.005138188,0.00004460252],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741811,0.00981121,0.0002169515,0.005021751,0.000133039,0.00004257619,0.002374395,0.000005522253,0.008213434],"genre_scores_gemma":[0.9987065,0.0005588299,0.00007345929,0.00008335063,0.00003993699,0.000007576516,0.0003959026,7.574301e-7,0.0001338681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00506547,"threshold_uncertainty_score":0.01236153,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2693607032521882,"score_gpt":0.364554289807682,"score_spread":0.09519358655549376,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}